|
1
|
Intusoma U, Nakorn CN and
Chotsampancharoen T: Intracranial hemorrhage in childhood acute
leukemia: Incidence, characteristics, and contributing factors.
Pediatr Neurol. 99:23–30. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park SH, Lee MJ, Park CJ, Jang S, Seo EJ,
Im HJ and Seo JJ: Bone marrow recovery of hematopoietic stem cells
and microenvironment after chemotherapy in childhood acute
lymphoblastic leukemia: Consecutive observations according to
chemotherapy schedule. Pediatr Hematol Oncol. 36:222–235. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rahmani M, Fardi M, Farshdousti Hagh M,
Hosseinpour Feizi AA, Talebi M and Solali S: An investigation of
methylation pattern changes in the IKZF1 promoter in patients with
childhood B-cell acute lymphoblastic leukemia. Blood Res.
54:144–148. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boulet-Craig A, Robaey P, Barlaam F,
Laniel J, Oswald V, Jerbi K, Sultan S, Affret-Bertout L, Drouin S,
Krajinovic M, et al: Visual short-term memory activation patterns
in adult survivors of childhood acute lymphoblastic leukemia.
Cancer. 125:3639–3648. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hara H, Kawamoto T, Fukase N, Kawakami Y,
Takemori T, Fujiwara S, Kitayama K, Nishida K, Kuroda R and Akisue
T: Gemcitabine and docetaxel combination chemotherapy for advanced
bone and soft tissue sarcomas: Protocol for an open-label,
non-randomised, Phase 2 study. BMC Cancer. 19:7252019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cornacchia MA, Coromilas AJ, Gallitano SM,
Frank RC and Halasz CL: Subacute cutaneous lupus erythematosus
induced by gemcitabine in 2 patients with pancreatic cancer. JAAD
Case Rep. 5:596–601. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Macchini M, Chiaravalli M, Zanon S,
Peretti U, Mazza E, Gianni L and Reni M: Chemotherapy in elderly
patients with pancreatic cancer: Efficacy, feasibility and future
perspectives. Cancer Treat Rev. 72:1–6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Simonson B and Das S: MicroRNA
therapeutics: The next magic bullet? Mini Rev Med Chem. 15:467–474.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pepin G and Gantier MP: microRNA Decay:
Refining microRNA regulatory activity. MicroRNA. 5:167–174. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanderova V, Kuzilkova D, Stuchly J,
Vaskova M, Brdicka T, Fiser K, Hrusak O, Lund-Johansen F and Kalina
T: High-resolution antibody array analysis of childhood acute
leukemia cells. Mol Cell Proteomics. 15:1246–1261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Madhusoodhan PP, Carroll WL and Bhatla T:
Progress and prospects in pediatric leukemia. Curr Probl Pediatr
Adolesc Health Care. 46:229–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wiemels J: Perspectives on the causes of
childhood leukemia. Chem Biol Interact. 196:59–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pui CH, Carroll WL, Meshinchi S and Arceci
RJ: Biology, risk stratification, and therapy of pediatric acute
leukemias: An update. J Clin Oncol. 29:551–565. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zimmermannova O, Zaliova M, Moorman AV,
Al-Shehhi H, Fronkova E, Zemanova Z, Kalina T, Vora A, Stary J,
Trka J, et al: Acute lymphoblastic leukemia with aleukemic
prodrome: Preleukemic dynamics and possible mechanisms of
immunosurveillance. Haematologica. 102:e225–e228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pålsson A, Malmström M and Follin C:
Childhood leukaemia survivors' experiences of long-term follow-ups
in an endocrine clinic - A focus-group study. Eur J Oncol Nurs.
26:19–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Umerez M, Garcia-Obregon S,
Martin-Guerrero I, Astigarraga I, Gutierrez-Camino A and
Garcia-Orad A: Role of miRNAs in treatment response and toxicity of
childhood acute lymphoblastic leukemia. Pharmacogenomics.
19:361–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Piatopoulou D, Avgeris M, Drakaki I,
Marmarinos A, Xagorari M, Baka M, Pourtsidis A, Kossiva L,
Gourgiotis D and Scorilas A: Clinical utility of miR-143/miR-182
levels in prognosis and risk stratification specificity of
BFM-treated childhood acute lymphoblastic leukemia. Ann Hematol.
97:1169–1182. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swellam M, Hashim M, Mahmoud MS, Ramadan A
and Hassan NM: Aberrant expression of some circulating miRNAs in
childhood acute lymphoblastic leukemia. Biochem Genet. 56:283–294.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jackstadt R and Hermeking H: MicroRNAs as
regulators and mediators of c-MYC function. Biochim Biophys Acta.
1849:544–553. 2015. View Article : Google Scholar : PubMed/NCBI
|
